Target intelligence / Profile preview

RIG-I dependent antiviral response regulator RNA (RDUR)

Target
RDUR
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA, Other
01

Overview

RIG-I dependent antiviral response regulator RNA (RDUR) is a long non-coding RNA (lncRNA) that is robustly upregulated upon infection with influenza A virus (IAV) and other viruses in a manner dependent on the RIG-I/NF-κB signaling pathway. RDUR promotes the host antiviral response by upregulating the expression of critical interferons (such as IFN-β) and interferon-stimulated genes (such as IFITM3, MX1, and ISG15), which suppress viral replication both in vitro and in vivo. RDUR achieves part of this activity by interacting with ILF2 and ILF3, proteins necessary for efficient ISG expression. Furthermore, RDUR provides feedback inhibition of NF-κB activation, thus restraining excessive inflammation during infection. Loss of RDUR expression leads to increased viral replication, heightened inflammation, tissue damage, and lower survival rates in animal models of IAV infection. RDUR maps to the human gene locus LINC02085 (previously LOC152225). RDUR is not a classic drug target (such as a receptor or enzyme) but is a regulatory RNA involved in innate immune regulation. There are no known drugs or established biomarkers or specific safety concerns directly related to manipulating RDUR as of current knowledge.

Other names
RIG-I-dependent IAV-upregulated noncoding RNALINC02085long intergenic non-protein coding RNA 2085LOC152225
02

Biological functions

Positive regulation of innate antiviral responseSuppression of viral replicationFeedback control of NF-κB activationRegulation of type I interferon (IFN) and interferon-stimulated gene (ISG) expressionModulation of inflammatory response
03

Disease associations

Infection (notably Influenza A virus and other viral infections)Inflammation (relevant to viral pathology and immune regulation)Other (potential implication in other viral or immune-related diseases; no direct implication in cancer, neurodegenerative, or cardiovascular diseases described so far)

Beyond the preview

Go deeper on RIG-I dependent antiviral response regulator RNA (RDUR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RIG-I dependent antiviral response regulator RNA (RDUR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call